1Drop Diagnostics

About:

1Drop Diagnostics is a cutting edge medical diagnostics and life science company.

Website: http://www.1dropdx.com

Twitter/X: 1DropDx

Top Investors: VentureOut, MassChallenge, Beat Schillig, Hans-Peter Strebel, Christian Wildmoser

Description:

1Drop Diagnostics is a cutting edge medical diagnostics and life science company. They combine the best techniques from microfluidics, biochemistry, photonics and information technology to build high performance point-of-care diagnostics devices. Their vision is to provide high quality medical information for everyone. They aim to increase access to quality healthcare by providing laboratory quality, easy to use, medical diagnostics in any setting. The 1Drop Diagnostics system is being developed for a broad menu of clinical applications including multiplexed assays of proteins, nucleic acids and peptides. Their first clinical applications are in the screening, diagnostics and monitoring of cardiovascular disease and infectious disease. Their mission is to improve patient lives by enabling precision medicine through non-invasive diagnostic tests providing actionable health information that is accessible to everyone at any time. They facilitate the early detection, prevention and management of disease. They empower people to live better lives.

Total Funding Amount:

$8.13M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Neuchâtel, Neuchatel, Switzerland

Founded Date:

2012-06-06

Contact Email:

info(AT)1dropdx.com

Founders:

Jörg Ziegler, Luc Gervais

Number of Employees:

11-50

Last Funding Date:

2018-10-31

IPO Status:

Private

Industries:

© 2025 bioDAO.ai